Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
The most common issues include nausea, vomiting, diarrhea, and constipation, especially in the early weeks or after increasing the dose
[7] Many healthcare providers recommend combining treatment with broader support, such as guidance from dietitians, therapists, or other healthcare professionals
This behavioral component is Nooms core competency and has been refined over more than a decade of product development
The new treatment a once-weekly injectable from Novo Nordisk, a Danish pharmaceutical company that has hired many leading diabetes and obesity scientists as consultants is poised to safely help many people with health-threatening obesity, physicians and researchers say
